from Form 8K. Why put this in if there was no hope of omontys to come back.
In consideration for the settlement of all outstanding payment and invoice amounts under the Bachem Agreement, the Company agreed to a payment of $5,000,000, as well as a contingent payment in the amount of $1,000,000 payable to Bachem upon the Company’s receipt of a first sale milestone payment from Takeda Pharmaceutical Company Limited, the Company’s licensee, if OMONTYS® is sold in the market in the future.
Didn't cost anything to put it that provision. Same as it did not cost Takeda any money to ink the $180M milestone/royalties with AFFY. Cannot say there is absolutely no hope for O to return. Just near zero chance O ever returns in time to save AFFY from a BK.